Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
| Image |  |
|---|---|
| Description | scientific article published on 16 April 2019 |
| Author/s |
author: Maria Podolak-Dawidziak |
| Publication date | April 16, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |